Gastrointestinal Hemorrhage: Clinical Trials

30 trials for Gastrointestinal Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 4 recruiting, 4 unknown, 3 terminated. 30 Phase 2, 7 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 230Completed 15, Recruiting 4, Unknown 4, Terminated 3, Not yet recruiting 2, Withdrawn 2
Phase 37Completed 3, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 11Terminated 1

Follow Gastrointestinal Hemorrhage: new trials by email Literature Review of Gastrointestinal Hemorrhage trials Research Report on Gastrointestinal Hemorrhage

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding
Trimebutine Maleate, Placebo - Acute Upper Gastrointestinal Bleeding, Upper Gastrointestinal Bleeding
Phase 2 / Phase 3Not yet recruitingAssiut University1002026-09-012026-08-06
Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic Ulcers
Tegoprazan tablet, Lansoprazole capsules - Peptic Ulcer Bleeding
Phase 2RecruitingUniversitas Indonesia1622026-08-062026-08-21
Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding
Vonorasan fumarate injection1, Vonorasan fumarate injection2, Esomeprazole sodium for injection - Peptic Ulcer Bleeding
Phase 2Not yet recruitingShandong New Time Pharmaceutical Co., LTD1502025-02-012025-01-20
Fecal Microbiota Transplantation for Radiation-Induced Proctopathy
Fecal Microbiota Transplantation Capsule - Radiation Induced Proctitis
Phase 2RecruitingSixth Affiliated Hospital, Sun Yat-sen University202025-02-012026-10-28
Dietary Supplements to Treat Radiation-Induced Rectal Injury
Butyrate - Radiotherapy, Radiation Proctitis
Phase 2RecruitingSixth Affiliated Hospital, Sun Yat-sen University332025-01-152026-08-07
Faecal Microbiota Transplantation for Liver Cirrhosis
Faecal microbiota transplantation, Placebo - Liver Cirrhosis
Phase 2 / Phase 3RecruitingUniversity of Aarhus2202021-07-012025-01-24
Diltiazem Ointment With Lidocaine vs. Nifedipine Ointment With Lidocaine Ointment for Treatment of Chronic Anal Fissure
2% Diltiazem ointment with 1.5% lidocaine, 0.3% Nifedipine ointment with 1.5% lidocaine - Fissure in Ano, Rectal Diseases
Phase 2 / Phase 3UnknownUniversity of Calgary4302021-06-012021-05-14
Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy
Azithromycin Injection, Metoclopramide Injectable Solution, Sodium chloride 0.9% - Gastro Intestinal Bleeding, Upper Gastrointestinal Bleeding
Phase 2UnknownWaihong Chung4352020-07-012020-08-07
Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD
Omega 3 fatty acids, Placebo - Heart Failure, Gastrointestinal Bleeding
Phase 1 / Phase 2TerminatedUniversity of Chicago352019-01-232021-07-13
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Isatuximab, Laboratory Biomarker Analysis - Amorphous, Eosinophilic, and Acellular Deposit, Constipation
Phase 2CompletedSWOG Cancer Research Network432018-06-062025-09-09
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
Octreotide LAR - Hereditary Hemorrhagic Telangiectasia, Gastrointestinal Hemorrhage
Phase 2UnknownRadboud University Medical Center152016-10-012018-04-20
Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding
Endo-Clot(TM) - Bleeding at Gastric Cancer
Phase 2UnknownYonsei University322016-04-012016-04-08
Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
Thalidomide, Placebo - Gastrointestinal Bleeding of Unknown Origin, Gastrointestinal Vascular Malformation
Phase 2WithdrawnZhizheng Ge2015-12-012016-04-21
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
Ilaprazole, omeprazole - Peptic Ulcer Hemorrhage
Phase 2CompletedLivzon Pharmaceutical Group Inc.1802014-02-012017-12-06
Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding
Desmopressin - Colorectal Cancer, Rectal Bleeding
Phase 2CompletedLaboratorio Elea Phoenix S.A.302013-04-012017-08-24
Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.
Argon Plasma Coagulation, Historical control - Radiation Injuries, Telangiectasis
Phase 2CompletedBarretos Cancer Hospital412013-01-012015-08-27
Transfusion in Gastrointestinal Bleeding
Restrictive transfusion policy, Liberal Transfusion Policy - Gastrointestinal Hemorrhage
Phase 2 / Phase 3CompletedDr Vipul Jairath9362012-09-012014-04-07
Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment Failure
Pasireotide, Placebo - Angiodysplasia
Phase 2CompletedRobert Benamouzig242012-03-012015-12-07
Emergency Capsule Endoscopy in Severe GI-bleeding
capsule endoscopy - GI-bleeding
Phase 2 / Phase 3CompletedTechnical University of Munich202011-12-012015-01-29
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
Ornithine-phenylacetate - Gastrointestinal Bleeding, Cirrhosis
Phase 2 / Phase 3CompletedHospital Universitari Vall d'Hebron Research Institute482011-10-012015-03-24

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Peptic Ulcer Hemorrhage (5)  ·  Angiodysplasia (4)  ·  Vascular Malformations (3)  ·  Diarrhea (2)  ·  Hemorrhage (2)  ·  Telangiectasia, Hereditary Hemorrhagic (2)  ·  Anemia (1)  ·  Arteriovenous Malformations (1)  ·  Ascites (1)  ·  Colitis, Ulcerative (1)  ·  Colorectal Neoplasms (1)  ·  Constipation (1)  ·  Fibrosis (1)  ·  Fissure in Ano (1)

Broader conditions

Digestive System Diseases (30)  ·  Gastrointestinal Diseases (30)  ·  Pathologic Processes (30)  ·  Pathological Conditions, Signs and Symptoms (30)  ·  Hemorrhage (28)  ·  Cardiovascular Diseases (8)  ·  Vascular Diseases (6)  ·  Cardiovascular Abnormalities (5)  ·  Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Intestinal Diseases (4)  ·  Neoplasms (4)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)

Interventions

Thalidomide (4)  ·  Esomeprazole (2)  ·  Fecal Microbiota Transplantation (2)  ·  Injections (2)  ·  Argon Plasma Coagulation (1)  ·  Azithromycin (1)  ·  Butyrates (1)  ·  Capsule Endoscopy (1)  ·  Deamino Arginine Vasopressin (1)  ·  Fatty Acids, Omega-3 (1)  ·  Historically Controlled Study (1)  ·  Iron (1)  ·  Lansoprazole (1)  ·  Lasers, Gas (1)  ·  Lidocaine (1)

Sponsors

Chinese University of Hong Kong (2)  ·  Shanghai Jiao Tong University School of Medicine (2)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (2)  ·  Assiut University (1)  ·  Barretos Cancer Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  Dana-Farber Cancer Institute (1)  ·  Dr Vipul Jairath (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Intermountain Health Care, Inc. (1)  ·  Laboratorio Elea Phoenix S.A. (1)  ·  Livzon Pharmaceutical Group Inc. (1)  ·  Northport Veterans Affairs Medical Center (1)  ·  Radboud University Medical Center (1)  ·  Robert Benamouzig (1)

Countries

United States (7)  ·  China (6)  ·  Canada (2)  ·  France (2)  ·  Hungary (2)  ·  Spain (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Greece (1)  ·  Indonesia (1)  ·  Latvia (1)

Top investigators

Zhizheng Ge, MD. Ph.D (2)  ·  Ann Nguyen, MD (1)  ·  Anthony V. D'Amico, MD, PhD (1)  ·  Atul Kumar, MD (1)  ·  Cindy K Barney, NNP (1)  ·  Emma Scott (1)  ·  Enrique Roca, MD (1)  ·  Hasan Maulahela, MD, PhD (1)  ·  James Gossage, MD (1)  ·  James YW Lau, MD (1)  ·  Joost Drenth, MD PhD (1)  ·  Joseph JY Sung, MD (1)

Results publications

PMID 12378346, PMID 17899453, PMID 19205735, PMID 20336314, PMID 21894577, PMID 23461895, PMID 23551344, PMID 23662891, PMID 23710797, PMID 24191271, PMID 24378191, PMID 24482669, PMID 24778009, PMID 25133029, PMID 25396330, PMID 25432532, PMID 25926146, PMID 25956718, PMID 26089283, PMID 26297133, PMID 29720248, PMID 32166534, PMID 39938959, PMID 40925099

NIH funding

2009 (1), U10CA180888 (1)